PT3833665T - Diazabiciclooctanonas como inibidores de serina betalactamases - Google Patents

Diazabiciclooctanonas como inibidores de serina betalactamases

Info

Publication number
PT3833665T
PT3833665T PT197558505T PT19755850T PT3833665T PT 3833665 T PT3833665 T PT 3833665T PT 197558505 T PT197558505 T PT 197558505T PT 19755850 T PT19755850 T PT 19755850T PT 3833665 T PT3833665 T PT 3833665T
Authority
PT
Portugal
Prior art keywords
diazabicyclooctanones
lactamases
inhibitors
serine beta
serine
Prior art date
Application number
PT197558505T
Other languages
English (en)
Original Assignee
Antabio Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antabio Sas filed Critical Antabio Sas
Publication of PT3833665T publication Critical patent/PT3833665T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT197558505T 2018-12-18 2019-08-08 Diazabiciclooctanonas como inibidores de serina betalactamases PT3833665T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18213635.8A EP3670512A1 (en) 2018-12-18 2018-12-18 Diazabicyclooctanones as inhibitors of serine beta-lactamases

Publications (1)

Publication Number Publication Date
PT3833665T true PT3833665T (pt) 2023-10-19

Family

ID=64745939

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197558505T PT3833665T (pt) 2018-12-18 2019-08-08 Diazabiciclooctanonas como inibidores de serina betalactamases

Country Status (4)

Country Link
EP (1) EP3670512A1 (pt)
EA (1) EA202190444A1 (pt)
MA (1) MA53270B1 (pt)
PT (1) PT3833665T (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2231667T3 (da) * 2008-01-18 2013-12-16 Merck Sharp & Dohme Beta-lactamase-hæmmere
ES2606059T3 (es) * 2011-08-30 2017-03-17 Wockhardt Limited Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona y su uso en el tratamiento de infecciones bacterianas
GB201310542D0 (en) 2013-06-13 2013-07-31 Antabio Sas Compounds
GB2533136A (en) 2014-12-11 2016-06-15 Antabio Sas Compounds
CN107501265B (zh) * 2017-10-09 2019-05-28 台州职业技术学院 一种7-氧代-二氮杂二环[3,2,1]辛烷衍生化合物及其制备方法和应用

Also Published As

Publication number Publication date
EA202190444A1 (ru) 2021-06-18
MA53270A (fr) 2022-04-06
MA53270B1 (fr) 2023-11-30
EP3670512A1 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
IL282535A (en) Transmuted 6-azabanzimidazole compounds as hpk1 inhibitors
IL268030A (en) Bicyclics as allosteric shp2 inhibitors
HK1246164A1 (zh) 作為絲氨酸蛋白酶抑制劑的被取代的吡唑化合物
EP3801503A4 (en) INHIBITORS OF SARM1
EP3906029A4 (en) INHIBITORS OF MENIN-MLL INTERACTION
ZA202100906B (en) Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP3609882A4 (en) HETEROCYCLIC INHIBITORS OF PCSK9
SG11202008925VA (en) Inhibitors of micro-rna 22
EP3801499A4 (en) INHIBITORS OF SARM1
IL269695A (en) Compounds useful as ALCAT 1 inhibitors
IL297413B2 (en) Use of Alkoxypyrazoles as nitrification inhibitors
EP3801500A4 (en) INHIBITORS OF SARM1
IL308476A (en) Inhibitors of the menin-mil interaction
EP3749365A4 (en) PEPTIDY INHIBITORS OF THE CALCINEURIN-NFAT INTERACTION
EP3801525A4 (en) PROLYL-ARNT-SYNTHETASE INHIBITORS
IL266223A (en) Drug inhibitors of kallikrein inhibitors
IL277866B1 (en) Aminothiazoles were substituted as nuclease inhibitors
IL283295A (en) gli1 inhibitors as therapeutic agents
IL277869A (en) Substituted propanamides as nuclease inhibitors
PT3833665T (pt) Diazabiciclooctanonas como inibidores de serina betalactamases
IL291368A (en) Inhibits expression of methadherin
AU2018901681A0 (en) Inhibitors of necroptosis
AU2017900935A0 (en) Heterocyclic inhibitors of PCSK9
AU2017904351A0 (en) Inhibitors of necroptosis